The estimated Net Worth of Holli Cherevka is at least $367 Thousand dollars as of 21 May 2021. Ms. Cherevka owns over 2,603 units of Ampio Pharmaceuticals Inc stock worth over $6 and over the last 6 years she sold AMPE stock worth over $0. In addition, she makes $367,000 as Chief Operating Officer at Ampio Pharmaceuticals Inc.
Holli has made over 2 trades of the Ampio Pharmaceuticals Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently she exercised 2,603 units of AMPE stock worth $1,328 on 21 May 2021.
The largest trade she's ever made was exercising 74,631 units of Ampio Pharmaceuticals Inc stock on 27 April 2021 worth over $38,062. On average, Holli trades about 9,654 units every 3 days since 2018. As of 21 May 2021 she still owns at least 2,603 units of Ampio Pharmaceuticals Inc stock.
You can see the complete history of Ms. Cherevka stock trades at the bottom of the page.
Holli Cherevka serves as Chief Operating Officer of the Company. Ms. Cherevka has served as our Chief Operating Officer (“COO”) since September 2017. Prior to taking her current role, Ms. Cherevka served as our Vice President of Operations and oversaw the clinical, regulatory and manufacturing operations. Since starting at Ampio in January 2013, she has held roles the following additional roles of increasing responsibility including: Director of Clinical Trials (January 2013 – November 2013), Senior Director of Clinical Trials (November 2013 – May 2015), Vice President of Operations (May 2015 – September 2017) and COO (September 2017 – current). Previously, Ms. Cherevka was the Director of Business Development at the American College of Radiology (ACR) Image Metrix from 2011 to 2013. Ms. Cherevka earned a Bachelor of Arts from California State University, Chico, and holds a Master of Science in Biomedical and Molecular Sciences Research from King’s College, London. Ms. Cherevka is a member of the Parenteral Drug Association, Colorado Bioscience Association and the International Society of Pharmaceutical Engineers, and a board member of the Professional Science Master’s in Biomedical Sciences (PSM) program at the University of Denver. She has represented Ampio Pharmaceuticals at conferences for the International Society of Pharmaceutical Engineers as well as at Global Investment Conferences and shareholder meetings.
As the Chief Operating Officer of Ampio Pharmaceuticals Inc, the total compensation of Holli Cherevka at Ampio Pharmaceuticals Inc is $367,000. There are 2 executives at Ampio Pharmaceuticals Inc getting paid more, with Michael E. Macaluso having the highest compensation of $457,040.
Holli Cherevka is 36, she's been the Chief Operating Officer of Ampio Pharmaceuticals Inc since 2017. There are 11 older and no younger executives at Ampio Pharmaceuticals Inc. The oldest executive at Ampio Pharmaceuticals Inc is Philip Coelho, 75, who is the Independent Director.
Holli's mailing address filed with the SEC is C/O AMPIO PHARMACEUTICALS, INC., 373 INVERNESS PARKWAY, SUITE 200, ENGLEWOOD, CO, 80112.
Over the last 13 years, insiders at Ampio Pharmaceuticals Inc have traded over $202,762 worth of Ampio Pharmaceuticals Inc stock and bought 377,748 units worth $116,063 . The most active insiders traders include Philip H Coelho, Joshua R. Disbrow, and J Kevin Buchi. On average, Ampio Pharmaceuticals Inc executives and independent directors trade stock every 192 days with the average trade being worth of $74. The most recent stock trade was executed by J Kevin Buchi on 9 June 2023, trading 21,858 units of AMPE stock currently worth $6,339.
ampio pharmaceuticals inc (ampe) is a biotechnology company located in 5445 dtc pkwy, greenwood village, colorado, united states.
Ampio Pharmaceuticals Inc executives and other stock owners filed with the SEC include: